In this CME Outfitters recorded Grand Rounds activity, expert faculty will guide participants through a discussion of the pathophysiology and associated complications of SBS, currently available and emerging SBS treatment strategies promoting enteral autonomy and reducing the need for PN, and how to develop interdisciplinary and interprofessional coordinated care plans for patients with SBS managed in the community setting.
1
02/10/2025
Anne Debra Feldman NP-C
Anne Debra Feldman NP-C
Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS
Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS
In this CME Outfitters recorded symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.
In this CME Outfitters livestream symposium, faculty will discuss the integration of guideline-based universal testing to address screening gaps for HIV, HBV, and HCV; evaluate pan-viral testing strategies that improve engagement in diverse practice settings; and explore strategies to incorporate guideline-recommended pan-viral and perinatal screenings into the care of patients who are pregnant to improve outcomes and limit perinatal transmission.
In this CME Outfitters live chapter meeting, expert faculty will discuss important strategies for identifying how to best overcome delays in insulin initiation as well as how to differentiate current and emerging basal insulin therapies and their impact on therapeutic inertia.
In this CME Outfitters Infographic, expert faculty will explore the role of new advanced therapies in UC treatment algorithms, facilitating the transition to these therapies in patients with UC who are non-/under-responsive to traditional treatments, and utilizing traditional treatments as well as available biologics and small-molecule therapies to optimize outcomes in patients with IP.
In this CME Outfitters recorded webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
1.5
12/20/2024
Laura M. De Castro, MD, MHSc
Laura M. De Castro, MD, MHSc
Santosh L. Saraf, MD
Santosh L. Saraf, MD
Moderator
Maya Bloomberg, MSN, APRN
Maya Bloomberg, MSN, APRN
Join our newsletter
Stay up to date on new CME Outfitters activities, breaking news, and important developments in medical education.